Literature DB >> 25408217

Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's disease.

Natalie S Ryan1, Tammaryn Lashley2, Tamas Revesz2, Kiran Dantu3, Nick C Fox1, Huw R Morris4.   

Abstract

Amyloid-related imaging abnormalities (ARIA), thought to reflect immune responses to vascular amyloid, have been detected in several amyloid-modifying therapy trials for Alzheimer's disease (AD). We report a case of ARIA developing spontaneously during the course of Presenilin 1 (PSEN1)-associated familial AD (FAD), in an APOE4 homozygous patient. Severe cerebral amyloid angiopathy with associated inflammation was subsequently found at autopsy. Recognition that ARIA may arise spontaneously during FAD and of the potential risk factors for its development are important observations given the recent launch of amyloid-modifying therapy trials for FAD.

Entities:  

Keywords:  APOE; Presenilin 1; cerebral amyloid angiopathy-related inflammation; familial Alzheimer's disease; magnetic resonance imaging

Mesh:

Substances:

Year:  2015        PMID: 25408217     DOI: 10.3233/JAD-142325

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Amyloid-Related Imaging Abnormalities in an Aged Squirrel Monkey with Cerebral Amyloid Angiopathy.

Authors:  Eric Heuer; Jessica Jacobs; Rebecca Du; Silun Wang; Orion P Keifer; Amarallys F Cintron; Jeromy Dooyema; Yuguang Meng; Xiaodong Zhang; Lary C Walker
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 2.  Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways.

Authors:  Steven M Greenberg; Brian J Bacskai; Mar Hernandez-Guillamon; Jeremy Pruzin; Reisa Sperling; Susanne J van Veluw
Journal:  Nat Rev Neurol       Date:  2019-12-11       Impact factor: 42.937

Review 3.  Anti-Aβ Autoantibodies in Amyloid Related Imaging Abnormalities (ARIA): Candidate Biomarker for Immunotherapy in Alzheimer's Disease and Cerebral Amyloid Angiopathy.

Authors:  Jacopo C DiFrancesco; Martina Longoni; Fabrizio Piazza
Journal:  Front Neurol       Date:  2015-09-25       Impact factor: 4.003

Review 4.  Cerebral Small Vessel Disease in Sporadic and Familial Alzheimer Disease.

Authors:  Rajesh N Kalaria; Diego Sepulveda-Falla
Journal:  Am J Pathol       Date:  2021-07-28       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.